Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for Pancreatic Fistula Prevention in Soft Pancreas
NCT01301222Phase 4Completed
- Sponsor
- PVS Memorial Hospital
- Start
- Sep 2010
- Primary completion
- Sep 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of Octreotide long-acting injection in pancreatic fistula (POPF), sponsored by PVS Memorial Hospital. Started Sep 2010; status: completed.
02
Drugs
Octreotide long-acting injection
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on NCT01301222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01301222.